HH Jarosz-Griffiths, L Gillgrass, LR Caley,
G Spoletini… - Plos one, 2024 - journals.plos.org
Inflammation is a key driver in the pathogenesis of cystic fibrosis (CF). We assessed the
effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on downregulating systemic …